Dr. Robert M. Dean, MD

Dr. Dean practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Dean's NPI, 1306800735, was assigned on April 13, 2006. Dr. Dean graduated from Perelman School of Medicine - Philadelphia in 1996. Dr. Dean holds Ohio license 35086450.

Dr. Dean's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Dean's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Dean is also affiliated with Medina Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Dean to 3 more hospitals and 2 clinical labs, each named with a free account. Dr. Dean's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Dean is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Dean's licenses on file in 2 states: Ohio and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Dean treats.

CMS data shows 696 Medicare services from Dr. Dean across 7 procedure codes in 2024, for 226 Medicare patients. Medicare paid $36,953 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 226 Medicare patients who saw Dr. Dean in 2024. The largest group is 65 to 74, with 101 patients. 72% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 68, with 44% women.

In 2024, Dr. Dean wrote 664 Medicare Part D claims for 104 patients. 69% of them were for generic drugs. CMS names the drug for 482 of them, across 14 drugs with 11 or more claims each, at $1,975,949 in total drug cost. In 2023, CMS named 431 claims across 14 drugs.

Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dean as offering telehealth.

Dmand AI links 132 papers to Dr. Dean, published from 2004 to 2025. 2017 was the busiest year, with 19. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Transplantation, Autologous. Dr. Dean has published most often in Bone Marrow Transplant. Dr. Dean's most frequent co-authors are Ronald M. Sobecks, MD, Brad L. Pohlman, MD and Brian J. Bolwell, MD.

CMS Open Payments shows 9 general payments to Dr. Dean from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Celgene Corporation paid the most, $297.

Dmand AI lists 1 award for Dr. Dean, most recently CMS Stage 1 EHR in 2013.

Dr. Dean graduated from Perelman School of Medicine - Philadelphia in 1996. Dr. Dean is a member of ACP, ASCO and ASH.

Dr. Dean is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.